ADHD specialist provider for shared care for medications across Northeast Sector (NES)

Description

An Urgent Award has been made for an ADHD specialist provider for shared care for medications across Northeast Sector (NES) as there is currently no commissioned service provider in place across Bury Oldham and HMR localities to support a cohort of patients with ADHD who require medication under shared care arrangements with Primary care and the provider, An urgent award is required to maintain continuity of care for the patients currently in titration or under shared care. There is a high clinical risk to patients whom require ongoing medication reviews and assessments. Patients can only be initiated on ADHD medication by a specialist provider and can only be prescribed ADHD medication in primary care under shared care arrangements with a specialist provider. This is because the medications are classed as AMBER drugs under the GMMMG Formulary. Patients on these drugs are required to have routine medication reviews by the specialist service to maintain safe prescribing. This contract is for 12 months starting 1 April 2024 - 31 March 2025 The contract value is £290,900.00 Lot 1: Award decision-makers: Corporate Director of Finance - Commissioning & Financial Assurance and the Executive Committee on behalf on NHS Greater Manchester Integrated Care Board. No conflicts or potential conflicts of interest of the individuals making the decision identified. The procurement falls outside the scope of application of the regulations Additional information: Award of a contract without prior publication of a call for competition in the cases listed below The procurement falls outside the scope of application of the regulations Explanation: The procurement falls outside the scope of application of the regulations as PSR